NCT06233045View on ClinicalTrials.gov

Dapagliflozin Tablet 10 mg Relative to Forxiga® Tablets 10 mg

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 23, 2024

Primary Completion Date

August 25, 2024

Study Completion Date

September 8, 2024

Conditions
Healthy Subjects
Interventions
DRUG

Dapagliflozin-Test product

Dapagliflozin tablet 10 mg Test product Manufactured by: ZYDUS LIFESCIENCES LIMITED, India

DRUG

Dapagliflozin-Reference product

Dapagliflozin tablet 10 mg Reference product Manufactured by: ASTRAZENECA PHARMACEUTICALS LP, USA

All Listed Sponsors
lead

Bio-innova Co., Ltd

INDUSTRY

NCT06233045 - Dapagliflozin Tablet 10 mg Relative to Forxiga® Tablets 10 mg | Biotech Hunter | Biotech Hunter